Jones Cleared To Fight At UFC 235

The Picogram rears its head once again on Thursday, as two of Jon Jones drug tests would be found to have trace amounts of turinabol.

While Jones would have adverse findings on February 14th and 15th, in a report from the Nevada State Athletic Commission released on Thursday, he did test negative on February 1st, 9th, and 18th.

The two positive tests would be at 40 picograms (2-14-19) and 20 picograms (2-15-19), both performed by the NSAC.

The tests were conducted by not only the UFC’s drug testing partner, USADA, but also the athletic commission themselves, and VADA, who Jones’ has been mandated to use for random drug tests, per a deal to be licensed in Nevada.

Dr. Daniel Eichner, President and Laboratory Director of SMRTL, who performed the tests, claimed in the report that Jones’ tests showed no evidence that the drug was re-administered. Dr. Eichner further provided that there is no scientific or medical evidence that Jones would have no unfair advantage leading up to or on his fight night against Anthony Smith on March 2nd at UFC 235.

Further results, reported by MMA Fighting show that Jones tested positive on January 6th and 7th for the M3 metabolite by VADA, plus the December 28th test which was reported on following UFC 232.

Jones will be cleared to fight in his first defense of the UFC light heavyweight title, which he won at UFC 232 on December 29th against Alexander Gustafsson, as he faces Anthony Smith.

For the full card of UFC 235 look below

Main card (PPV at 10 p.m. ET)

Jon Jones vs. Anthony Smith

Tyron Woodley vs. Kamaru Usman

Robbie Lawler (170) vs. Ben Askren

Tecia Torres vs. Weili Zhang

Cody Garbrandt vs. Pedro Munhoz

Undercard (ESPN at 8 p.m. ET)

Jeremy Stephens vs. Zabit Magomedsharipov

Misha Cirkunov vs. Johnny Walker

Cody Stamann vs. Alejandro Perez

Diego Sanchez vs. Mickey Gall

Undercard (UFC Fight Pass at 6:30 p.m. ET)

Edmen Shahbazyan vs. Charles Byrd

Gina Mazany vs. Macy Chiasson

Polyana Viana vs. Hannah Cifers

You might also like
By using our site you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Service. X